No Data
Express News | Alto Neuroscience Inc - Maturity Date Extended to January 1, 2029
Express News | Alto Neuroscience Inc - Amends Loan and Security Agreement
Alto Neuroscience Initiated at Buy by Jones Trading
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
JonesTrading Initiates Alto Neuroscience(ANRO.US) With Buy Rating, Announces Target Price $18
Express News | Alto Neuroscience Highlights Data From Precision Psychiatry Platform At ACNP Annual Meeting; Interim Analysis For ALTO-300 Phase 2b Trial In MDD Expected Q1 2025, With Topline Results In H1 2025